A Phase 4, Multicenter, Prospective, Non-Interventional, Observational Study to Investigate the Effectiveness and Safety/Tolerability of Perampanel When Used as First Adjunctive Therapy in Routine Clinical Practice in People with Epilepsy: Study 512
AuthID
P-018-SX2
P-018-SX2